JNJ Stock Analysis: Johnson & Johnson

BullRecon tracks Johnson & Johnson (JNJ) with public stock signals, momentum, fundamentals, volume context, news interest and risk indicators. Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Sector
Healthcare
Industry
Drug Manufacturers - General
Latest close
$271.11
20-day change
+8.18%
Revenue growth
+6.05%
BullRecon bias
BULLISH
Price history points
120
Opening BullRecon...
Checking your session.